Chung S J, Fung H L
Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo 14260.
Biochem Pharmacol. 1993 Jan 7;45(1):157-63. doi: 10.1016/0006-2952(93)90388-d.
We have shown previously that nitric oxide (NO) is generated from nitroglycerin (NTG) through enzyme-mediated reactions in the bovine coronary artery smooth muscle cell, but it is not known whether this metabolic conversion plays a significant role in the pharmacologic action of NTG, viz. relaxation. In this study, we developed a technique that allowed direct measurement of NO from intact bovine coronary arterial rings that were incubated previously with NTG, and examined whether changes in NTG-induced relaxation were accompanied by parallel changes in NO generation. Co-incubation of the vascular preparations with a potent inhibitor of glutathione-S-transferases (GSTs), bromosulfophthalein (up to 200 microM), did not affect NTG-induced relaxation, nor did it alter NO generation from NTG in the preparation. In contrast, 1-chloro-2,4-dinitrobenzene (CDNB), a GST substrate, inhibited NO generation as well as the relaxation response of NTG in the intact vascular tissue preparation. CDNB, however, did not decrease the relaxant responses of nifedipine and isoproterenol. Thus, the inhibitory effect of CDNB on NTG-induced relaxation and NO production appeared specific. When bovine coronary rings were made tolerant to NTG by pretreatment with 0.44 mM NTG for 1 hr, the EC50 was shifted to the right 162-fold, and NO generation was also reduced in intact rings and tissue homogenates. However, when the homogenates were further subfractionated to microsomes and cytosols, or when homogenates were allowed to stand for a similar time period necessary for subfractionation, the difference in NO production from control versus tolerant tissue preparations disappeared. It is possible, therefore, that the NTG-induced tolerance process might have been partially reversed during this time period. Results of this study identified CDNB as an apparently specific inhibitor of NTG action, but showed that GST-mediated reactions were probably not involved in the metabolic activation of NTG. Our results also indicated that tissue NO generation from NTG was positively related to the relaxation responses generated by this nitrovasodilator.
我们之前已经表明,在牛冠状动脉平滑肌细胞中,一氧化氮(NO)是通过酶介导的反应由硝酸甘油(NTG)产生的,但尚不清楚这种代谢转化在NTG的药理作用即舒张作用中是否起重要作用。在本研究中,我们开发了一种技术,可直接测量预先用NTG孵育的完整牛冠状动脉环中的NO,并研究NTG诱导的舒张变化是否伴随着NO生成的平行变化。将血管制剂与谷胱甘肽-S-转移酶(GSTs)的强效抑制剂溴磺酞(高达200 microM)共同孵育,既不影响NTG诱导的舒张,也不改变制剂中NTG产生的NO。相反,GST底物1-氯-2,4-二硝基苯(CDNB)抑制完整血管组织制剂中NTG的NO生成以及舒张反应。然而,CDNB并未降低硝苯地平和异丙肾上腺素的舒张反应。因此,CDNB对NTG诱导的舒张和NO产生的抑制作用似乎具有特异性。当通过用0.44 mM NTG预处理1小时使牛冠状动脉环对NTG产生耐受性时,半数有效浓度(EC50)向右移动162倍,完整环和组织匀浆中的NO生成也减少。然而,当将匀浆进一步亚分级为微粒体和胞质溶胶时,或者当匀浆放置一段与亚分级所需时间相似的时间段时,对照组织制剂与耐受组织制剂之间NO产生的差异消失。因此,在此时间段内,NTG诱导的耐受过程可能已部分逆转。本研究结果确定CDNB为NTG作用的明显特异性抑制剂,但表明GST介导的反应可能不参与NTG的代谢活化。我们的结果还表明,NTG产生的组织NO与这种硝基血管扩张剂产生的舒张反应呈正相关。